HTG Molecular Diagnostics Inc (STU:65H)
€ 0.242 0 (0%) Market Cap: 1,000.00 Enterprise Value: -2.44 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q2 2021 HTG Molecular Diagnostics Inc Earnings Call Transcript

Aug 12, 2021 / 08:30PM GMT
Release Date Price: €59.04 (-4.47%)
Operator

Greetings, and welcome to HTG Molecular Diagnostics Second Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn this conference over to your host, Ms. Monique Kosse, LifeSci Advisors. Ma'am, you may begin your presentation.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, operator. Earlier today, HTG released its financial results for the second quarter ended June 30, 2021.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond HTG's control, including uncertainties regarding the ongoing COVID-19 pandemic and its impacts on HTG and its customers, that may cause actual circumstances, events or results to differ materially from those projected on today's call.

Factors that could cause events or results to differ materially include those risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot